Cargando…
Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
BACKGROUND: Diabetic macular edema (DME) can cause severe vision impairments for patients with diabetes. Recently, Conbercept has shown efficacy on DME with 3-monthly loading dose injection and pro re nata (PRN, 3+PRN) thereafter in retrospectivetrials. Furthermore, there are some other approaches h...
Autores principales: | Ba, Teer, Zhou, Lili, Zhang, Han, Zhang, Xiaoguang, Guo, Shixuan, Li, Huixia, Tian, Haiyan, Caihan, Qiqige, Bai, Gang, Zhou, Jing, Qi, Lao, Zhang, Xueyan, Zhang, Guisen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458221/ https://www.ncbi.nlm.nih.gov/pubmed/32871950 http://dx.doi.org/10.1097/MD.0000000000021992 |
Ejemplares similares
-
Microvascular Changes After Conbercept Intravitreal Injection of PDR With or Without Center-Involved Diabetic Macular Edema Analyzed by OCTA
por: Lin, Wei, et al.
Publicado: (2022) -
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018) -
Conbercept and Retinal Photocoagulation in the treatment of Diabetic Macular Edema
por: Meng, Weizhe, et al.
Publicado: (2019) -
EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
por: Sun, Zuhua, et al.
Publicado: (2017) -
Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines
por: Zhan, Hui-Qin, et al.
Publicado: (2023)